Devonian Health Group Inc. (DVHGF)
OTC
Closed
Oct 6, 2026
Day's Range
4.9452 wk Range
4.27Overview - DVHGF - Devonian Health Group Inc.
Key Statistics
Valuation
Enterprise Value
11.06M
P/E (Trailing)
‪-2.38‬
PEG Ratio
‪0.03‬
Price / Sales (TTM)
‪5.45‬
Price / Book
‪3.30‬
EV / EBITDA
‪-2.66‬
Profitability
Gross Margin
‪111.29%‬
Profit Margin
‪-204.08%‬
Operating Margin
‪-1,096.22%‬
Return on Assets
‪-24.50%‬
Return on Equity
‪-77.32%‬
Ownership
Shares Outstanding
2.78M
Float
2.10M
Held by Insiders
‪12.03%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.24‬
50-Day Avg
‪11.50‬
200-Day Avg
‪11.50‬
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - DVHGF - Devonian Health Group Inc.
Peers - DVHGF - Devonian Health Group Inc.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
Profile Summary - DVHGF - Devonian Health Group Inc.
About
Devonian Health Group Inc. is a pharmaceutical company specializing in the development and commercialization of botanical drugs and cosmeceutical products. Focusing on leveraging plant-based compounds, Devonian Health aims to address niche markets in dermatology, particularly targeting anti-aging and anti-inflammatory…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
